An antibody-free bio-layer interferometry biosensor for immunoglobulin G1 detection in human serum by using molecularly imprinted polynorepinephrine.

Bio-Layer Interferometry (BLI) has emerged as a versatile technique in affinity-based biosensing, analogous to Surface Plasmon Resonance. BLI enables real-time, label-free detection, and quantification of biomolecular interactions between an immobilized receptor and an analyte in solution. The BLI sensor comprises an optical fiber with an internal reference layer at the end and an external biocompatible layer where biological receptors are immobilized and exposed to the solution.

Fate of fluoroquinolones associated with antimicrobial resistance in circular periurban agriculture.

Animal antibiotic use contributes to antimicrobial resistance (AMR) in humans. While animal manure benefits soil fertility, it also acts as hotspot for antibiotic residues, antibiotic-resistant bacteria, and their genes. Amending soils with poultry litter is recognized as "magic" among horticulture farmers and it remains a common practice globally.

Fast, sensitive, and sustainable colorimetric detection of chlorogenic acid in artichoke waste material.

Caffeoylquinic acids (CQAs) are nutraceutical polyphenols highly represented in natural sources, including artichoke waste (AW). In this study a colorimetric method for rapid and sustainable detection of a 5-CQA isomer (Chlorogenic acid) in AW extract was developed by using alkaline Tris buffer (10 mmol L, pH 9) to generate a yellow color associated with 5- to 3-CQA isomerization reaction, as suggested by NMR and MS analyses. The strong absorbance at 360 nm was followed by standard UV-Vis methodology.

Online and Offline Aggressive Behaviors in Adolescence: The Role of Self-Regulatory Self-Efficacy Beliefs.

Self-regulatory self-efficacy belief (i.e., SRSE) represents a fundamental factor for adjustment in adolescence, as a vehicle to promote positive behaviors and protect youths from transgressions and maladjustment.

Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database.

Aims: This study aimed to assess the proportions of type 2 diabetes (T2D) subjects meeting cardiovascular outcome trials (CVOTs) criteria for sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and estimate SGLT2i utilization, along with associated demographic and clinical characteristics, in a primary care setting.

Methods: T2D patients in Italy were selected between January 1, 2021, and December 31, 2022, from The Health Improvement Network (THIN) database. Representativeness was determined by dividing patients meeting key inclusion criteria for four CVOTs (CANVAS, DECLARE-TIMI 58, EMPA-REG OUTCOME, VERTIS-CV) to the total T2D population.